References
- Acebedo AR, Amor EC, Jacinto SD (2014). Apoptosis-inducing activity of HPLC fraction from Voacanga globosa (Blanco) Merr. on the human colon carcinoma cell. Asian Pac J Cancer Prev, 15, 617-22. https://doi.org/10.7314/APJCP.2014.15.2.617
- Asmaa MJ, Al-Jamal HA, Ang CY, et al (2014). Apoptosis induction in MV4-11 and K562 human leukemic cells by Pereskia sacharosa (Cactaceae) leaf crude extract. Asian Pac J Cancer Prev, 15, 475-81. https://doi.org/10.7314/APJCP.2014.15.1.475
- Bewry NN, Nair RR, Emmons MF, et al (2008). Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther, 7, 3169-75. https://doi.org/10.1158/1535-7163.MCT-08-0314
- Chahardouli B, Zaker F, Mousavi SA, et al (2013). Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance. Hematology, 18, 158-62. https://doi.org/10.1179/1607845412Y.0000000050
- Chen MB, Zhang Y, Wei MX, et al (2013). Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Cellular signalling, 25, 1993-2002. https://doi.org/10.1016/j.cellsig.2013.05.026
- Colie S, Van Veldhoven PP, Kedjouar B, et al (2009). Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Cancer Res, 69, 9346-53. https://doi.org/10.1158/0008-5472.CAN-09-2198
- Corbin AS, Agarwal A, Loriaux M, et al (2011). Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest, 121, 396-409. https://doi.org/10.1172/JCI35721
- De Angel RE, Smith SM, Glickman RD, Perkins SN, Hursting SD (2010). Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr Cancer, 62, 1074-86. https://doi.org/10.1080/01635581.2010.492092
- Deininger MW, Goldman JM, Melo JV (2000). The molecular biology of chronic myeloid leukemia. Blood, 96, 3343-56.
- Druker BJ, Guilhot F, O'Brien SG, et al (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med, 355, 2408-17. https://doi.org/10.1056/NEJMoa062867
- Fan GH, Wang ZM, Yang X, et al (2014). Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling. Asian Pac J Cancer Prev, 15, 677-82. https://doi.org/10.7314/APJCP.2014.15.2.677
- Fujiwara Y, Takaishi K, Nakao J, et al (2013). Corosolic acid enhances the antitumor effects of chemotherapy on epithelial ovarian cancer by inhibiting signal transducer and activator of transcription 3 signaling. Oncol Lett, 6, 1619-23. https://doi.org/10.3892/ol.2013.1591
- Gambacorti-Passerini CB, Gunby RH, Piazza R, et al (2003). Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias. Lancet Oncol, 4, 75-85. https://doi.org/10.1016/S1470-2045(03)00979-3
- Gao J, Sun CR, Yang JH, et al (2011). Evaluation of the hepatoprotective and antioxidant activities of Rubus parvifolius L. J Zhejiang Univ Sci B, 12, 135-42. https://doi.org/10.1631/jzus.B1000117
- Ge Y, Cheng R, Zhou Y, et al (2012). Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E. Mol Cell Biochem, 368, 17-25. https://doi.org/10.1007/s11010-012-1338-3
- Gu Y, Chen T, Meng Z, et al (2012). CaMKII gamma, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. Blood, 120, 4829-39. https://doi.org/10.1182/blood-2012-06-434894
- Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. https://doi.org/10.1016/j.cell.2011.02.013
- Huang XJ, Ren W, Li J, Chen LY, Mei ZN (2013). Anti-inflammatory and anticancer activities of ethanol extract of pendulous monkshood root in vitro. Asian Pac J Cancer Prev, 14, 3569-73. https://doi.org/10.7314/APJCP.2013.14.6.3569
- Indran IR, Tufo G, Pervaiz S, Brenner C (2011). Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta, 1807, 735-45. https://doi.org/10.1016/j.bbabio.2011.03.010
- Ji C, Yang B, Yang YL, et al (2010). Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene, 29, 6557-68. https://doi.org/10.1038/onc.2010.379
- Kim I, He YY (2013). Targeting the AMP-activated protein kinase for cancer prevention and therapy. Front Oncol, 3, 175.
- Kma L (2013). Roles of plant extracts and constituents in cervical cancer therapy. Asian Pac J Cancer Prev, 14, 3429-36. https://doi.org/10.7314/APJCP.2013.14.6.3429
- Li T, Xu WS, Wu GS, et al (2014). Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in hepG2 hepatocellular carcinoma cells. Asian Pac J Cancer Prev, 15, 1745-49. https://doi.org/10.7314/APJCP.2014.15.4.1745
- Ma LD, Zhou M, Wen SH, et al (2010). Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells. Leuk Lymphoma, 51, 1326-36. https://doi.org/10.3109/10428194.2010.483748
- Mao X, Yu CR, Li WH, Li WX (2008). Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res, 18, 879-88. https://doi.org/10.1038/cr.2008.86
- Vakana E, Altman JK, Glaser H, Donato NJ, Platanias LC (2011). Antileukemic effects of AMPK activators on BCR-ABL-expressing cells. Blood, 118, 6399-402. https://doi.org/10.1182/blood-2011-01-332783
- Zhang XJ, Xu XF, Gao RL, Xu JF (2014). Rubus parvifolius L. inhibited the growth of leukemia K562 cells in vitro and in vivo. Chin J Integr Med, 20, 36-42. https://doi.org/10.1007/s11655-013-1537-0
- Zheng L, Zhang YM, Zhan YZ, Liu CX (2014). Momordica cochinchinensis seed extracts suppress migration and invasion of human breast cancer ZR-75-30 cells via down-regulating MMP-2 and MMP-9. Asian Pac J Cancer Prev, 15, 1105-10. https://doi.org/10.7314/APJCP.2014.15.3.1105
Cited by
- Potential targets of energy restriction mimetic agents in cancer cells vol.10, pp.16, 2014, https://doi.org/10.2217/fon.14.191
- Rutin mediated targeting of signaling machinery in cancer cells vol.14, pp.1, 2014, https://doi.org/10.1186/s12935-014-0124-6
- Cryptotanshinone suppresses the proliferation and induces the apoptosis of pancreatic cancer cells via the STAT3 signaling pathway vol.12, pp.5, 2015, https://doi.org/10.3892/mmr.2015.4379
- Parameters Involved in Autophosphorylation in Chronic Myeloid Leukemia: a Systems Biology Approach vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5273
- Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines vol.35, pp.5, 2016, https://doi.org/10.1177/0960327115595686
- AS1041, a Novel Synthesized Derivative of Marine Natural Compound Aspergiolide A, Arrests Cell Cycle, Induces Apoptosis, and Inhibits ERK Activation in K562 Cells vol.15, pp.11, 2017, https://doi.org/10.3390/md15110346
- Saponins as adipokines modulator: A possible therapeutic intervention for type 2 diabetes vol.8, pp.7, 2017, https://doi.org/10.4239/wjd.v8.i7.337
- Relevance of functional foods in the Mediterranean diet: the role of olive oil, berries and honey in the prevention of cancer and cardiovascular diseases pp.1549-7852, 2018, https://doi.org/10.1080/10408398.2018.1526165
- Total Saponins of Rubus Parvifolius L. Exhibited Anti-Leukemia Effect in vivo through STAT3 and eIF4E Signaling Pathways pp.1993-0402, 2018, https://doi.org/10.1007/s11655-018-2563-8